| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 01/17/2012 | US8097589 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; inhibiting mucous release into airways of patients; immunotherapy |
| 01/17/2012 | US8097587 IGF-I protein variants for treating IGFBP-1-related disorders |
| 01/17/2012 | US8097453 Recombinant viral-based malaria vaccines |
| 01/17/2012 | US8097274 Skin substitutes, preparation methods and uses thereof |
| 01/17/2012 | US8097255 Mammalian receptor protein DCRS5; methods of treatment |
| 01/17/2012 | US8097247 Probiotic, lactic acid-producing bacteria and uses thereof |
| 01/17/2012 | US8097239 use of a polyhydroxy component for increasing the solubility of a bioactive compound, especially a peptide in a lipid-based controlled-release matrix; bioadhesive |
| 01/17/2012 | US8097236 The invention relates to an internal therapeutic product comprising: (i) an anti-cancer component selected from one or both of: a radionucleotide, a cytotoxic drug; and (ii) a silicon component selected from one or more of: resorbable |
| 01/17/2012 | US8096972 Devices for intraocular drug delivery |
| 01/17/2012 | CA2499597C Multistage formulation containing a biguanide and thiazolidindione derivatives |
| 01/17/2012 | CA2485852C Agent for binding a plurality of c-reactive protein and their use in the treatment and prevention of tissue damage |
| 01/17/2012 | CA2484640C Vitamin-mitomycin conjugates |
| 01/17/2012 | CA2484269C Compounds and method for coating surfaces in a haemocompatible manner |
| 01/17/2012 | CA2473986C Indazole compounds useful as protein kinase inhibitors |
| 01/17/2012 | CA2461915C Isolation and cultivation of microorganisms from natural environments and drug discovery based thereon |
| 01/17/2012 | CA2429998C Intraocular implants for preventing transplant rejection in the eye |
| 01/17/2012 | CA2320371C Inotropic and diuretic effects of exendin and glp-1 |
| 01/17/2012 | CA2148712C Peripheralization of hematopoietic stem cells |
| 01/15/2012 | CA2746087A1 Use of preventing and treating inflammation |
| 01/12/2012 | WO2012006552A1 Combinations of kinase inhibitors for the treatment of cancer |
| 01/12/2012 | WO2012005379A1 Transformant obtained by introducing gm1 gene and crmp2 gene |
| 01/12/2012 | WO2012005227A1 Tetrahydrocarboline derivative |
| 01/12/2012 | WO2012004800A1 Use of fts and analogs to treat non-autoimmune-allergic and non-allergic inflammatory conditions |
| 01/12/2012 | WO2012004799A1 Treatment of delayed cutaneous hypersensitivity conditions with s-farnesylthiosalicylic acid and analogs thereof |
| 01/12/2012 | WO2012003968A1 Novel gastro- retentive dosage forms comprising a gaba analog and an opioid |
| 01/12/2012 | WO2011129427A9 Diagnostic agent and therapeutic agent for cancer |
| 01/12/2012 | WO2011087765A3 Methods of producing stabilized solid pharmaceutical compositions containing morphinans |
| 01/12/2012 | WO2010134048A3 Topical retinoid solutions |
| 01/12/2012 | WO2002036070A3 Novel fish chemokine and methods for use |
| 01/12/2012 | US20120010295 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 01/12/2012 | US20120010278 Use of Artemisinin for Treating Tumors Induced by Oncogenic Viruses and for Treating Viral Infections |
| 01/12/2012 | US20120010225 Pharmaceutical composition |
| 01/12/2012 | US20120010127 Compositions Comprising Multiple Bioactive Agents, and Methods of Using the Same |
| 01/12/2012 | US20120009648 DNA polymerase lambda and uses thereof |
| 01/12/2012 | US20120009613 Pharmaceutical composition for modulating the activity of a novel triglyceride hydrolase |
| 01/12/2012 | US20120009253 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds of the lower respiratory tract |
| 01/12/2012 | US20120009152 Nitric oxide donors for treatment of disease and injury |
| 01/12/2012 | US20120006748 Buffered compositions for dialysis |
| 01/12/2012 | CA2803900A1 Combinations of kinase inhibitors for the treatment of cancer |
| 01/12/2012 | CA2802216A1 Tetrahydrocarboline derivative |
| 01/12/2012 | CA2801620A1 Novel gastro-retentive dosage forms comprising a gaba analog and an opioid |
| 01/11/2012 | EP2404608A1 Combination use of cholestanol derivative |
| 01/11/2012 | EP2404600A1 Use of the combination of a sinus current If inhibitor and an inhibitor of the angiotensin conversion enzyme for treating cardiac insufficiency |
| 01/11/2012 | EP2403551A2 Silk fibroin systems for antibiotic delivery |
| 01/11/2012 | EP2403534A1 Pharmaceutical compositions active in preventing, stabilizing and treating alzheimer's disease |
| 01/11/2012 | EP2403507A1 Treatment of infection |
| 01/11/2012 | EP2403502A1 Medicinal cosmetic lipoatrophy |
| 01/11/2012 | EP2403498A2 Enhancing coagulation or reducing fibrinolysis |
| 01/11/2012 | EP2403497A1 Compounds, compositions and use for anticancer therapy |
| 01/11/2012 | EP2403494A2 Kinase protein binding inhibitors |
| 01/11/2012 | EP2403491A2 Alkylglycerols and alkoxyglycerols for increasing endogenous plasmalogen levels in mammals |
| 01/11/2012 | EP2403335A1 Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (rtki) compounds to the eye |
| 01/11/2012 | EP1750703B1 Method for reducing gastrointestinal toxicity due to the administration of tegafur |
| 01/11/2012 | EP1402070B1 Methods for the diagnosis of cancer based on the obcam and ntm genes |
| 01/11/2012 | EP1381377B1 A composition including a ginkgolide and apocynin which interferes with the arachidonic acid cascade |
| 01/11/2012 | EP1180932B1 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof |
| 01/11/2012 | EP1019432B1 The ob receptor and methods of diagnosing and treating weight |
| 01/11/2012 | CN102316900A Aniline derivative having anti-rna viral activity |
| 01/11/2012 | CN102316876A High dosage doramectin formulation |
| 01/11/2012 | CN102316870A Sgc stimulators of sgc activators in combination with pde5 inhbitors for the treatment of erectile dysfunction |
| 01/11/2012 | CN102316869A Method of treating cancer |
| 01/11/2012 | CN102316861A Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitor, and uses thereof |
| 01/11/2012 | CN102309765A Long-acting anticoagulant polypeptide including immunoglobulin Fc segments as carriers and preparation method of same |
| 01/11/2012 | CN102309758A Medicinal composition for treating diseases caused by enterovirus infections |
| 01/11/2012 | CN102309757A Novel regulatory factor of FOXP3 and regulatory T cells, and use thereof |
| 01/11/2012 | CN102309756A Compound medicament containing phosphodiesterase 4 inhibitor and glucocorticoid and used for treating dermatosis |
| 01/11/2012 | CN102309755A Design scheme for compound type dual duplex locating type intracellular vaccine |
| 01/11/2012 | CN102309752A Protein related to brain ageing and Alzheimer's disease and application thereof |
| 01/11/2012 | CN102309473A Antimicrobial compositons containing synergistic combinations of quaternary ammonium compounds and essential oils and/or constituents thereof |
| 01/11/2012 | CN101721710B Cholesteryl-carboxymethyl Curdlan nanometer particle and preparing method |
| 01/11/2012 | CN101675922B Parakeratosis inhibitor, pore-shrinking agent and skin preparation for external use |
| 01/11/2012 | CN101543631B Microspherical substrate containing beeswax, pharmaceutical composition containing microspherical substrate and application thereof |
| 01/11/2012 | CN101198354B Preventive or remedy for glaucoma |
| 01/11/2012 | CN101002940B Medicine composition for treating polycystic renal disease and its uses |
| 01/10/2012 | US8093300 Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism |
| 01/10/2012 | US8093293 containing nondenatured plant extracts including legume and vegetable extracts having trypsin inhibitory activity and a natural or synthetic retinoid or retinol compounds |
| 01/10/2012 | US8093230 Supersaturated aqueous ifosfamide compositions |
| 01/10/2012 | US8093217 For sensitizing multi-drug resistant cancer or radiation resistant cancer cells to chemotherapeutic agents |
| 01/10/2012 | US8092846 Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines |
| 01/10/2012 | US8092833 Compositions containing inclusion complexes |
| 01/10/2012 | US8092831 A safe and effective twelve to twenty-four hour formulation comprising a decongestant core which has a delay release coating and an immediate release coating of both drugs, a water soluble binder and surfactant; one-a-day orally |
| 01/10/2012 | US8092781 Treatment of sinusitis in mammals with clostridia neurotoxins |
| 01/10/2012 | US8092608 Administering oligosaccharides |
| 01/10/2012 | CA2496797C Therapeutic agent for glaucoma comprising rho kinase inhibitor and prostaglandin |
| 01/10/2012 | CA2483855C Methods for increasing the therapeutic response to electroconvulsive therapy ("ect") |
| 01/10/2012 | CA2479666C (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| 01/10/2012 | CA2464334C Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 01/10/2012 | CA2460141C Drugs comprising combination of antithrombotic agent with pyrazolone derivative |
| 01/10/2012 | CA2455559C Methods to mobilize progenitor/stem cells |
| 01/10/2012 | CA2454339C Methods for preventing antipsychotic-induced weight gain |
| 01/10/2012 | CA2444692C Use of neuronal sodium channel antagonists for the control of ectoparasites in homeothermic animals |
| 01/10/2012 | CA2440605C Methods for treating stress disorders using glucocorticoid receptor-specific antagonists |
| 01/10/2012 | CA2427261C Aged companion pet diet |
| 01/10/2012 | CA2419541C Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 01/10/2012 | CA2404488C Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis |
| 01/10/2012 | CA2398726C High purity lipopeptides, lipopeptide micelles and processes for preparing same |
| 01/10/2012 | CA2334483C Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof |
| 01/05/2012 | WO2012003349A2 Dissolvable fibrous web structure article comprising active agents |
| 01/05/2012 | WO2012003338A1 COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET |
| 01/05/2012 | WO2012002921A1 Multiple dosage forms comprising fenofibrate or fenofibric acid in combination with hmg co a reductase inhibitors such as statins |